I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Lech-Marańda, Ewa
147
results:
Search for persons
X
Format
Online (147)
Mediatypes
E-Books (2)
Articles (Online) (86)
OpenAccess-fulltext (59)
Sorted by: Relevance
Sorted by: Year
?
1
Pirtobrutinib, a highly selective, non-covalent (reversible..:
Wierda, William G
;
Shah, Nirav N
;
Cheah, Chan Y
...
The Lancet Haematology. , 2024
Link:
https://doi.org/10.1016/..
?
2
Characteristics of patients with newly diagnosed hematologi..:
Kępski, Jarosław
;
Szmit, Sebastian
;
Lech-Marańda, Ewa
Frontiers in Oncology. 14 (2024) - p. , 2024
Link:
https://doi.org/10.3389/..
?
3
Asciminib stands out as the superior tyrosine kinase inhibi..:
Domka, Krzysztof
;
Dąbkowska, Agnieszka
;
Janowska, Martyna
...
Haematologica. , 2024
Link:
https://doi.org/10.3324/..
?
4
Real-World Outcome and Prognostic Factors in MDS Patients T..:
Wiśniewski, Kamil
;
Pruszczyk-Matusiak, Katarzyna
;
Puła, Bartosz
..
Cancers. 16 (2024) 7 - p. 1333 , 2024
Link:
https://doi.org/10.3390/..
?
5
P1103: OBINUTUZUMAB INDUCTION AND MAINTENANCE IN PATIENTS W..:
Wróbel, Tomasz
;
Kalicinska, Elzbieta
;
Maciej Zaucha, Jan
...
HemaSphere. 7 (2023) S3 - p. e4339598 , 2023
Link:
https://doi.org/10.1097/..
?
6
Clinical outcomes of patients with myelofibrosis after imme..:
Mesa, Ruben
;
Verstovsek, Srdan
;
Platzbecker, Uwe
...
Haematologica. 109 (2023) 2 - p. 676-681 , 2023
Link:
https://doi.org/10.3324/..
?
7
P1108: EFFICACY OF PIRTOBRUTINIB, A HIGHLY SELECTIVE, NON-C..:
Scarfò, Lydia
;
Patel, Manish R.
;
Eyre, Toby A.
...
HemaSphere. 7 (2023) S3 - p. e852670f , 2023
Link:
https://doi.org/10.1097/..
?
8
Early efficacy and safety of obinutuzumab with chemotherapy..:
Paszkiewicz-Kozik, Ewa
;
Hus, Iwona
;
Palka, Monika
...
Advances in Clinical and Experimental Medicine. 32 (2023) 1 - p. 131-136 , 2023
Link:
https://doi.org/10.17219..
?
9
Clinical efficacy and tolerability of venetoclax plus ritux..:
Soboń, Anita
;
Drozd-Sokołowska, Joanna
;
Paszkiewicz-Kozik, Ewa
...
Annals of Hematology. 102 (2023) 8 - p. 2119-2126 , 2023
Link:
https://doi.org/10.1007/..
?
10
P526: SAFETY AND EFFICACY UPDATE FROM CLI120-001: A PHASE1B..:
Lech-Marańda, Ewa
;
Szymańska, Agata
;
Zaucha, Jan
...
HemaSphere. 7 (2023) S3 - p. e27994b8 , 2023
Link:
https://doi.org/10.1097/..
?
11
CRL4CRBN E3 Ligase Complex as a Therapeutic Target in Multi..:
Barankiewicz, Joanna
;
Salomon-Perzyński, Aleksander
;
Misiewicz-Krzemińska, Irena
.
Cancers. 14 (2022) 18 - p. 4492 , 2022
Link:
https://doi.org/10.3390/..
?
12
MCL-133 Pirtobrutinib, a Highly Selective, Non-Covalent (Re..:
Cohen, Jonathon B.
;
Shah, Nirav N.
;
Alencar, Alvaro J.
...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) - p. S394-S395 , 2022
Link:
https://doi.org/10.1016/..
?
13
CLL-120 Pirtobrutinib, A Highly Selective, Non-Covalent (Re..:
Coombs, Catherine C.
;
Pagel, John M.
;
Shah, Nirav N.
...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) - p. S268-S269 , 2022
Link:
https://doi.org/10.1016/..
?
14
Targeting arginase-1 exerts antitumor effects in multiple m..:
Ramji, Kavita
;
Grzywa, Tomasz M.
;
Sosnowska, Anna
...
Scientific Reports. 12 (2022) 1 - p. , 2022
Link:
https://doi.org/10.1038/..
?
15
Poster: MCL-133 Pirtobrutinib, a Highly Selective, Non-Cova..:
Cohen, Jonathon B.
;
Shah, Nirav N.
;
Alencar, Alvaro J.
...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) - p. S175 , 2022
Link:
https://doi.org/10.1016/..
1-15